Svennilson Peter
CIK
1606074
Location
SAN FRANCISCO, CA
Portfolio Value
Small
$632,712,973
Diversification
Highly concentrated
Filing Date
Global Rank
#1,405
/ 5,288
▲ 185
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
+28.9%
Period ended 5 years ago
Filed Nov 4, 2020 · 5y
3 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+249.6%
SPY
+76.3%
Annualised alpha
+31.0%
Max drawdown
−57.6%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
3 positions · as of Sep 30, 2020 · Δ vs Jun 30, 2020Top Position
43.9%
−11.3 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
3,670
Highly concentrated−709
Portfolio Trend
3 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2020| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $632,712,973 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reducedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarter
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| NRIX | Nurix Therapeutics, Inc. | 6,755,881 | $235,847,805 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| RCUS | Arcus Biosciences, Inc. | 1,767,676 | $43,732,304 | |
| No positions match the current search. | ||||
3 positions ·
$632,712,973 total
· as of Sep 30, 2020
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Held | 7,977,384 | $277,612,962 | 43.88% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
NEW | 6,755,881 | $235,847,805 | 37.28% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Held | 4,768,181 | $119,252,206 | 18.85% |